Post-Transplantation Lymphoproliferative Disorder After Kidney Transplantation: Report of a Nationwide French Registry and the Development of a New Prognostic Score

Adult Male MESH: Registries Adolescent 610 MESH: Multivariate Analysis MESH: Prognosis MESH: Kidney Transplantation Young Adult 03 medical and health sciences MESH: Lymphoproliferative Disorders Postoperative Complications 0302 clinical medicine MESH: Risk Factors Risk Factors MESH: Postoperative Complications 616 Humans Prospective Studies Registries Aged MESH: Adolescent MESH: Aged MESH: Middle Aged MESH: Humans MESH: Adult MESH: Follow-Up Studies [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences Middle Aged Prognosis Kidney Transplantation Survival Analysis MESH: Prospective Studies MESH: Male Lymphoproliferative Disorders 3. Good health MESH: France [SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences MESH: Young Adult MESH: Survival Analysis Multivariate Analysis Female France MESH: Female Follow-Up Studies
DOI: 10.1200/jco.2012.43.2344 Publication Date: 2013-02-20T02:32:25Z
ABSTRACT
Purpose Post-transplantation lymphoproliferative disorder (PTLD) is associated with significant mortality in kidney transplant recipients. We conducted a prospective survey of the occurrence of PTLD in a French nationwide population of adult kidney recipients over 10 years. Patients and Methods A French registry was established to cover a nationwide population of transplant recipients and prospectively enroll all adult kidney recipients who developed PTLD between January 1, 1998, and December 31, 2007. Five hundred patient cases of PTLD were referred to the French registry. The prognostic factors for PTLD were investigated using Kaplan-Meier and Cox analyses. Results Patients with PTLD had a 5-year survival rate of 53% and 10-year survival rate of 45%. Multivariable analyses revealed that age > 55 years, serum creatinine level > 133 μmol/L, elevated lactate dehydrogenase levels, disseminated lymphoma, brain localization, invasion of serous membranes, monomorphic PTLD, and T-cell PTLD were independent prognostic indicators of poor survival. Considering five variables at diagnosis (age, serum creatinine, lactate dehydrogenase, PTLD localization, and histology), we constructed a prognostic score that classified patients with PTLD as being at low, moderate, high, or very high risk for death. The 10-year survival rate was 85% for low-, 80% for moderate-, 56% for high-, and 0% for very high–risk recipients. Conclusion This nationwide study highlights the prognostic factors for PTLD and enables the development of a new prognostic score. After validation in an independent cohort, the use of this score should allow treatment strategies to be better tailored to individual patients in the future.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (124)